Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/21698| Title: | DDR Alterations as a Surrogate Marker for TMB in SCLC - Use it or Lose it? | Austin Authors: | Arulananda, Surein;Mitchell, Paul L R ;John, Thomas | Affiliation: | School of Cancer Medicine, La Trobe University, Heidelberg, Australia Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia School of Cancer Medicine, La Trobe University, Heidelberg, Australia Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Sep-2019 | Publication information: | Journal of thoracic oncology 2019; 14(9): 1498-1500 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/21698 | DOI: | 10.1016/j.jtho.2019.06.025 | ORCID: | 0000-0002-5636-6381 | Journal: | Journal of thoracic oncology | PubMed URL: | 31445727 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.